Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study

[1] Wild S(2004)Global prevalence of diabetes: estimates for 2000 and projections for 2030 Diabetes Care 27 1047-53

[2] Roglic G(1999)Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation. 100 1134-46

[3] Green A(1998)Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med. 339 229-34

[4] Sicree R(2001)Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes Diabetologia 44 S14-S21

[5] King H(1998)Management of dyslipidemia in adults with diabetes American Diabetes Association. Diabetes Care. 21 179-82

[6] Grundy SM(2001)Clinical review 124: Diabetic dyslipidemia: causes and consequences J Clin Endocrinol Metab. 86 965-71

[7] Benjamin IJ(2002)Diabetic dyslipidemia Atheroscler Suppl. 3 47-51

[8] Burke GL(2008)Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis Lancet. 371 117-25

[9] Chait A(2006)Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials BMJ. 332 1115-24

[10] Eckel RH(2008)'Real-life' reduction in cholesterol with statins, 1993 to 2002 Br J Clin Pharmacol. 65 587-92

[1] Wild S(2004)Global prevalence of diabetes: estimates for 2000 and projections for 2030 Diabetes Care 27 1047-53

[2] Roglic G(1999)Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation. 100 1134-46

[3] Green A(1998)Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med. 339 229-34

[4] Sicree R(2001)Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes Diabetologia 44 S14-S21

[5] King H(1998)Management of dyslipidemia in adults with diabetes American Diabetes Association. Diabetes Care. 21 179-82

[6] Grundy SM(2001)Clinical review 124: Diabetic dyslipidemia: causes and consequences J Clin Endocrinol Metab. 86 965-71

[7] Benjamin IJ(2002)Diabetic dyslipidemia Atheroscler Suppl. 3 47-51

[8] Burke GL(2008)Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis Lancet. 371 117-25

[9] Chait A(2006)Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials BMJ. 332 1115-24

[10] Eckel RH(2008)'Real-life' reduction in cholesterol with statins, 1993 to 2002 Br J Clin Pharmacol. 65 587-92